Based on previous studies, minor-elevation (1 μg/ml) and moderate-elevation (2.5 μg/ml) dosages of CRP were used to represent the clinical features of a chronic inflammation process in obesity and in chronic diseases (Gewurz et al., 1982; Soinio et al., 2006). Here, CRP is linked to obesity disorder.